Study to Evaluate the Long-Term Safety, Tolerability, and Biological Activity of ATYR1940 in Patients With Limb Girdle and Facioscapulohumeral Muscular Dystrophy

< b > Conditions < /b > :   Facioscapulohumeral Muscular Dystrophy;   Limb Girdle Muscular Dystrophy < br/ > < b > Intervention < /b > :   Drug: ATYR1940 < br/ > < b > Sponsor < /b > :   aTyr Pharma, Inc. < br/ > < b > Enrolling by invitation < /b > - verified July 2016
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials